Agilent Technologies Inc (NYSE:A) Given Consensus Recommendation of “Buy” by Brokerages

Shares of Agilent Technologies Inc (NYSE:A) have earned a consensus rating of “Buy” from the seventeen ratings firms that are presently covering the firm, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is $86.17.

A has been the subject of a number of recent analyst reports. Zacks Investment Research cut shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Thursday, May 16th. Barclays cut their price target on shares of Agilent Technologies from $88.00 to $86.00 and set an “overweight” rating for the company in a research note on Wednesday, May 15th. Wolfe Research initiated coverage on shares of Agilent Technologies in a research note on Thursday, May 30th. They issued a “peer perform” rating for the company. UBS Group initiated coverage on shares of Agilent Technologies in a research note on Friday, March 15th. They issued a “buy” rating and a $92.00 price target for the company. Finally, Cowen increased their price target on shares of Agilent Technologies from $80.00 to $90.00 and gave the company an “outperform” rating in a research note on Tuesday, March 26th.

In other news, SVP Michael Tang sold 6,728 shares of the firm’s stock in a transaction dated Wednesday, March 27th. The shares were sold at an average price of $80.50, for a total transaction of $541,604.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Paul N. Clark sold 2,823 shares of the firm’s stock in a transaction dated Wednesday, March 27th. The stock was sold at an average price of $80.31, for a total transaction of $226,715.13. Following the sale, the director now owns 88,857 shares of the company’s stock, valued at approximately $7,136,105.67. The disclosure for this sale can be found here.

Large investors have recently added to or reduced their stakes in the stock. Destination Wealth Management increased its position in Agilent Technologies by 100.0% during the first quarter. Destination Wealth Management now owns 400 shares of the medical research company’s stock worth $32,000 after acquiring an additional 200 shares during the period. Captrust Financial Advisors increased its position in Agilent Technologies by 2,121.1% during the fourth quarter. Captrust Financial Advisors now owns 422 shares of the medical research company’s stock worth $29,000 after acquiring an additional 403 shares during the period. Lake Point Wealth Management bought a new position in Agilent Technologies during the fourth quarter worth about $30,000. JOYN Advisors Inc. increased its position in Agilent Technologies by 186.6% during the fourth quarter. JOYN Advisors Inc. now owns 470 shares of the medical research company’s stock worth $32,000 after acquiring an additional 306 shares during the period. Finally, Truehand Inc bought a new position in Agilent Technologies during the fourth quarter worth about $33,000.

A traded up $0.02 during trading hours on Tuesday, hitting $73.34. 3,096,151 shares of the company’s stock were exchanged, compared to its average volume of 2,268,093. Agilent Technologies has a 1-year low of $60.42 and a 1-year high of $82.27. The stock has a market capitalization of $23.17 billion, a price-to-earnings ratio of 26.29, a PEG ratio of 2.04 and a beta of 1.40. The company has a current ratio of 3.41, a quick ratio of 2.82 and a debt-to-equity ratio of 0.35.

Agilent Technologies (NYSE:A) last announced its earnings results on Tuesday, May 14th. The medical research company reported $0.71 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.72 by ($0.01). Agilent Technologies had a return on equity of 19.71% and a net margin of 22.25%. The business had revenue of $1.24 billion for the quarter, compared to analyst estimates of $1.27 billion. During the same quarter in the previous year, the company posted $0.65 EPS. The business’s revenue for the quarter was up 2.7% compared to the same quarter last year. As a group, research analysts predict that Agilent Technologies will post 3.05 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 24th. Stockholders of record on Tuesday, July 2nd will be paid a dividend of $0.164 per share. This represents a $0.66 dividend on an annualized basis and a dividend yield of 0.89%. The ex-dividend date is Monday, July 1st. Agilent Technologies’s dividend payout ratio is presently 23.66%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

See Also: Portfolio Manager

Analyst Recommendations for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.